Document is current
Any future updates will be listed below
-
Authors
Hudson, Johnny
Kaeberlein, Tammi
Mahal, Akashdeep
Wong, Nelson
Ghorbanifarajzadeh, Mina
Radella, Frank
Isman, Anar
Nyquist, Andy
Zalzala, Sajad
Haddad, George
Kaeberlein, Matt https://orcid.org/0000-0002-1311-3421
An, Jonathan Y. https://orcid.org/0000-0001-8422-8608
-
Funding
Funding for this research was provided by:
Norn Group (AWD-007726)
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 22 May 2024
First Online: 6 June 2024
Declarations
:
: MK is a co-founder of the Optispan Geroscience, which has no material interest in rapamycin or rapamycin derivative production or sales at this time. AI, AN, and SZ are employees and/or shareholders of the Ageless Rx, a longevity focused telemedicine platform that sponsors several clinical trials, including interventional and observational efforts for the repurposed use of rapamycin. MG is currently the senior clinical manager at the Overjet Inc.
